Therapeutic Solutions International (OTCMKTS:TSOI – Get Rating) is one of 352 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare Therapeutic Solutions International to similar companies based on the strength of its profitability, earnings, valuation, dividends, institutional ownership, risk and analyst recommendations.
Profitability
This table compares Therapeutic Solutions International and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Therapeutic Solutions International | N/A | N/A | N/A |
| Therapeutic Solutions International Competitors | -2,783.24% | -412.52% | -20.05% |
Analyst Ratings
This is a summary of recent ratings and recommmendations for Therapeutic Solutions International and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Therapeutic Solutions International | 0 | 0 | 0 | 0 | N/A |
| Therapeutic Solutions International Competitors | 290 | 1525 | 4108 | 45 | 2.65 |
Valuation & Earnings
This table compares Therapeutic Solutions International and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Therapeutic Solutions International | N/A | N/A | -0.20 |
| Therapeutic Solutions International Competitors | $122.17 million | -$13.54 million | 55.21 |
Therapeutic Solutions International’s rivals have higher revenue, but lower earnings than Therapeutic Solutions International. Therapeutic Solutions International is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Insider & Institutional Ownership
5.6% of Therapeutic Solutions International shares are owned by institutional investors. Comparatively, 26.2% of shares of all “Biotechnology” companies are owned by institutional investors. 27.2% of shares of all “Biotechnology” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Therapeutic Solutions International rivals beat Therapeutic Solutions International on 5 of the 8 factors compared.
Therapeutic Solutions International Company Profile
Therapeutic Solutions International, Inc. engages in the provision of immune modulation for the treatment of several specific diseases. The firm is also involved in developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, traumatic brain injury, and for daily health. The company was founded on August 6, 2007 and is headquartered in Elk, ID.
Receive News & Ratings for Therapeutic Solutions International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapeutic Solutions International and related companies with MarketBeat.com's FREE daily email newsletter.
